Alfieri Michele, Guerra Federico, Lofiego Carla, Fogante Marco, Ciliberti Giuseppe, Vagnarelli Fabio, Barbarossa Alessandro, Principi Samuele, Stronati Giulia, Volpato Giovanni, Compagnucci Paolo, Valeri Yari, Tofoni Paolo, Brugiatelli Leonardo, Capodaglio Irene, Esposto Pirani Paolo, Argalia Giulio, Schicchi Nicolò, Messano Loredana, Centanni Maurizio, Giovagnoni Andrea, Perna Gian Piero, Dello Russo Antonio, Casella Michela
Cardiology and Arrhythmology Clinic, University Hospital "Azienda Ospedaliero-Universitaria delle Marche", Via Conca 71, 60126 Ancona, Italy.
Department of Biomedical Sciences and Public Health, Marche Polytechnic University, 60121 Ancona, Italy.
Medicina (Kaunas). 2024 Apr 8;60(4):613. doi: 10.3390/medicina60040613.
: Cardiac magnetic resonance (CMR) imaging has become an essential instrument in the study of cardiomyopathies; it has recently been integrated into the diagnostic workflow for cardiac amyloidosis (CA) with remarkable results. An additional emerging role is the stratification of the arrhythmogenic risk by scar analysis and the possibility of merging these data with electro-anatomical maps. This is made possible by using a software (ADAS 3D, Galgo Medical, Barcelona, Spain) able to provide 3D heart models by detecting fibrosis along the whole thickness of the myocardial walls. Little is known regarding the applications of this software in the wide spectrum of cardiomyopathies and the potential benefits have yet to be discovered. In this study, we tried to apply the ADAS 3D in the context of CA. : This study was a retrospectively analysis of consecutive CMR imaging of patients affected by CA that were treated in our center (Marche University Hospital). Wherever possible, the data were processed with the ADAS 3D software and analyzed for a correlation between the morphometric parameters and follow-up events. The outcome was a composite of all-cause mortality, unplanned cardiovascular hospitalizations, sustained ventricular arrhythmias (VAs), permanent reduction in left ventricular ejection fraction, and pacemaker implantation. The secondary outcomes were the need for a pacemaker implantation and sustained VAs. : A total of 14 patients were deemed eligible for the software analysis: 8 patients with wild type transthyretin CA, 5 with light chain CA, and 1 with transthyretin hereditary CA. The vast majority of imaging features was not related to the composite outcome, but atrial wall thickening displayed a significant association with both the primary ( = 0.003) and the secondary outcome of pacemaker implantation ( = 0.003). The software was able to differentiate between core zones and border zones of scars, with the latter being the most extensively represented in all patients. Interestingly, in a huge percentage of CMR images, the software identified the highest degree of core zone fibrosis among the epicardial layers and, in those patients, we found a higher incidence of the primary outcome, without reaching statistical significance ( = 0.18). Channels were found in the scar zones in a substantial percentage of patients without a clear correlation with follow-up events. : CMR imaging plays a pivotal role in cardiovascular diagnostics. Our analysis shows the feasibility and applicability of such instrument for all types of CA. We could not only differentiate between different layers of scars, but we were also able to identify the presence of fibrosis channels among the different scar zones. None of the data derived from the ADAS 3D software seemed to be related to cardiac events in the follow-up, but this might be imputable to the restricted number of patients enrolled in the study.
心脏磁共振成像(CMR)已成为心肌病研究中的重要工具;最近它已被纳入心脏淀粉样变性(CA)的诊断流程,并取得了显著成果。另一个新出现的作用是通过瘢痕分析对心律失常风险进行分层,以及将这些数据与电解剖图合并的可能性。这可以通过使用一款软件(ADAS 3D,Galgo Medical,西班牙巴塞罗那)来实现,该软件能够通过检测心肌壁全层的纤维化来提供三维心脏模型。关于该软件在广泛的心肌病中的应用知之甚少,其潜在益处还有待发现。在本研究中,我们试图在CA的背景下应用ADAS 3D。
本研究是对在我们中心(马尔凯大学医院)接受治疗的CA患者的连续CMR成像进行的回顾性分析。只要有可能,就使用ADAS 3D软件处理数据,并分析形态学参数与随访事件之间的相关性。结局是全因死亡率、非计划心血管住院、持续性室性心律失常(VAs)、左心室射血分数永久性降低以及起搏器植入的综合结果。次要结局是起搏器植入的必要性和持续性VAs。
共有14名患者被认为符合软件分析条件:8名野生型转甲状腺素蛋白CA患者、5名轻链CA患者和1名转甲状腺素蛋白遗传性CA患者。绝大多数影像学特征与综合结局无关,但心房壁增厚与起搏器植入的主要结局(P = 0.003)和次要结局(P = 0.003)均显示出显著相关性。该软件能够区分瘢痕的核心区和边缘区,后者在所有患者中占比最大。有趣的是,在很大比例的CMR图像中,该软件在心肌外层中识别出最高程度的核心区纤维化,并且在这些患者中,我们发现主要结局的发生率较高,但未达到统计学显著性(P = 0.18)。在相当比例的患者的瘢痕区发现了通道,但与随访事件无明显相关性。
CMR成像在心血管诊断中起着关键作用。我们的分析表明了这种仪器对所有类型CA的可行性和适用性。我们不仅能够区分瘢痕的不同层,还能够识别不同瘢痕区中纤维化通道的存在。从ADAS 3D软件得出的数据似乎均与随访中的心脏事件无关,但这可能归因于本研究纳入的患者数量有限。